Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB1801264	沙格列汀二甲双胍缓释片(II)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2018-10-24	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Filed	2018-10-25	view
JYHB1801508	沙格列汀二甲双胍缓释片(II)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2019-01-28	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2019-09-29	view
JYHB1801510	沙格列汀二甲双胍缓释片(I)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2019-01-28	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2019-09-29	view
JYHB1801263	沙格列汀二甲双胍缓释片(II)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2018-10-24	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Filed	2018-10-25	view
JYHB1801507	沙格列汀二甲双胍缓释片(I)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2019-01-28	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2019-09-29	view
JYHB1801509	沙格列汀二甲双胍缓释片(III)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2019-01-28	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2019-09-29	view
JYHB2001401	沙格列汀二甲双胍缓释片(III)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2020-08-21	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Filed	2020-09-02	view
JYHB1801512	沙格列汀二甲双胍缓释片(III)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2019-01-28	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2019-09-29	view
JYHB1801266	沙格列汀二甲双胍缓释片(III)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2018-10-24	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Filed	2018-10-25	view
JYHB2001400	沙格列汀二甲双胍缓释片(II)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2020-08-21	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Filed	2020-09-02	view
JYHB1801262	沙格列汀二甲双胍缓释片(I)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2018-10-24	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Filed	2018-10-25	view
JYHB1801265	沙格列汀二甲双胍缓释片(III)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2018-10-24	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Filed	2018-10-25	view
JYHB2001399	沙格列汀二甲双胍缓释片(I)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2020-08-21	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Filed	2020-09-02	view
JYHB1801261	沙格列汀二甲双胍缓释片(I)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2018-10-24	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Filed	2018-10-25	view
JYHB1801511	沙格列汀二甲双胍缓释片(II)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2019-01-28	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2019-09-29	view
JYHB2001834	沙格列汀二甲双胍缓释片(I)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2020-09-21	阿斯利康制药有限公司	Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Filed	2020-10-12	view
JYHB1700837	沙格列汀二甲双胍缓释片(II)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2017-06-21	阿斯利康制药有限公司	Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2018-06-04	view
JYHB1700742	沙格列汀二甲双胍缓释片(II)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2017-06-05	阿斯利康制药有限公司	Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2017-07-17	view
JYHF1700055	沙格列汀二甲双胍缓释片(III)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2017-06-22	阿斯利康制药有限公司	Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2017-08-01	view
JYHF1700057	沙格列汀二甲双胍缓释片(II)	metformin hydrochloride;saxagliptin	Tablet, extended release	Chemical Drugs	Supplementary Application	2017-06-22	阿斯利康制药有限公司	Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2017-08-01	view